Dear

We are delighted to announce that Xeros, a Parkwalk portfolio company, successfully listed on AIM today.

Parkwalk first invested in October 2010, at 33.0p per share equivalent (26.4p net of initial tax relief), and the IPO price of 123p represents a 4.65x tax-free return for our investors in a little over three years. At this level, this exit alone would return more to investors than their entire subscription into the Parkwalk Fund I.

Meanwhile, another portfolio company, Horizon Discovery, is also listing on AIM later this week (as highlighted in the Daily Telegraph today here) - this should also show a significant uplift for our investors.

Finally, this year's Parkwalk Fund V will close to new investors in the coming weeks - please contact the team on 020 7759 2288 or by clicking here if you would like more details.

Parkwalk invests in high-growth British technology companies across all stages of their development, from formation through to AIM-listed companies. 
Currently all of our fully invested Funds are valued at a premium to their investment cost, both with and without the tax reliefs of the EIS.

Valuations as of 25th March 2014. Net NAV includes income tax relief and fees on investment

Parkwalk’s current portfolio consists of 27 companies, which have raised in excess of £200m of funding between them since 2010 and over 600 patents protect their technology and processes.
Overall, Funds I-IV’s portfolio comprises of 9% Series ‘A’, 33% Series ‘B’, 25% Pre-IPO and 33% AIM listed.  

Past performance is no guide to future performance. The price of a fund can fall as well as rise. Investors may receive back less than originally invested.